XML 15 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities    
Net income (loss) $ 127,068 $ (26,033)
Adjustments to reconcile net (income) loss to net cash used in operating activities:    
Gain on sale of business (172,289) 0
Stock-based compensation expense 8,824 9,009
Amortization of acquired intangible assets 0 898
Depreciation and amortization 1,408 3,273
Accretion of discount on short-term investments, net (632) (841)
Unrealized loss on equity investments 3,494 0
Non-cash lease expense 1,355 1,438
Provision for excess and obsolete inventory 696 815
Change in fair value of warrants 0 (232)
Change in fair value of contingent consideration 0 (3,400)
Other non-cash items 67 385
Changes in assets and liabilities:    
Accounts receivable, net (1,858) (2,021)
Inventory 1,935 (3,817)
Prepaid expenses and other assets (1,592) 112
Deferred tax asset, non-current 38,359 390
Accounts payable (1,224) (578)
Accrued liabilities (20,785) (7,753)
Deferred revenue (29,934) (527)
Operating lease liabilities (1,490) (1,504)
Other liabilities 1 103
Net cash used in operating activities (46,597) (30,283)
Investing activities    
Cash received for sale of business, net 363,222 0
Purchases of short-term marketable debt securities (127,208) (32,321)
Purchases of long-term marketable debt securities (58,517) 0
Purchases of marketable equity securities (837) 0
Proceeds from sales and maturities of investments 15,000 52,000
Purchases of property and equipment (570) (5,054)
Net cash provided by investing activities 191,090 14,625
Financing activities    
Payments for taxes related to net share settlement of equity awards and other (118) (46)
Proceeds from exercise of stock options 78 0
Net cash used in financing activities (40) (46)
Effect of foreign exchange rate fluctuations on cash and cash equivalents 115 357
Net increase (decrease) in cash, cash equivalents and restricted cash 144,568 (15,347)
Cash, cash equivalents and restricted cash at beginning of period 123,296 168,818
Cash, cash equivalents and restricted cash at end of period 267,864 153,471
Supplemental disclosures of cash flow information    
Contingent consideration receivable for sale of SomaScan Business 25,000 0
Cash paid for interest 4 4
Cash paid for income taxes (9) (201)
Purchases of property and equipment included in accounts payable 319 1,135
Non-cash right-of-use assets and lease liabilities 8,175 20
Asset retirement obligations $ 820 $ 645